Fang Luo

534 total citations
17 papers, 398 citations indexed

About

Fang Luo is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cancer Research. According to data from OpenAlex, Fang Luo has authored 17 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Computational Theory and Mathematics and 5 papers in Cancer Research. Recurrent topics in Fang Luo's work include Computational Drug Discovery Methods (6 papers), Microbial Natural Products and Biosynthesis (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Fang Luo is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Microbial Natural Products and Biosynthesis (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Fang Luo collaborates with scholars based in China, Israel and United States. Fang Luo's co-authors include Dan Li, Cong Liu, Wenyuan Wang, Jiangyong Gu, Xiaojie Xu, Lirong Chen, Guanghong Wei, Yi Zhang, Bin Dai and Jun Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Fang Luo

17 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Luo China 10 248 144 69 59 56 17 398
I-Lin Lu Taiwan 13 295 1.2× 94 0.7× 38 0.6× 175 3.0× 93 1.7× 19 640
Benjamin L. Barthel United States 11 190 0.8× 42 0.3× 38 0.6× 27 0.5× 56 1.0× 13 373
Ho‐Man Chan Hong Kong 13 420 1.7× 80 0.6× 122 1.8× 27 0.5× 40 0.7× 21 732
Fei Peng China 15 203 0.8× 70 0.5× 27 0.4× 13 0.2× 226 4.0× 40 569
Debasmita Dutta United States 13 246 1.0× 98 0.7× 22 0.3× 7 0.1× 50 0.9× 29 478
Thomas J. Paul United States 13 214 0.9× 46 0.3× 78 1.1× 52 0.9× 53 0.9× 19 418
Huaijiang Xiang China 12 210 0.8× 26 0.2× 85 1.2× 55 0.9× 30 0.5× 19 452
Matthew E. Cuellar United States 9 255 1.0× 18 0.1× 32 0.5× 32 0.5× 84 1.5× 14 356
Jia Ni China 15 146 0.6× 78 0.5× 11 0.2× 15 0.3× 42 0.8× 27 515
Paul A. Hubbard United States 11 279 1.1× 19 0.1× 36 0.5× 30 0.5× 23 0.4× 14 474

Countries citing papers authored by Fang Luo

Since Specialization
Citations

This map shows the geographic impact of Fang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Luo more than expected).

Fields of papers citing papers by Fang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Luo. The network helps show where Fang Luo may publish in the future.

Co-authorship network of co-authors of Fang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Luo. A scholar is included among the top collaborators of Fang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Luo. Fang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Sun, Xiuna, Hanyang Li, Yang Zhang, et al.. (2024). PDCdb: the biological activity and pharmaceutical information of peptide–drug conjugate (PDC). Nucleic Acids Research. 53(D1). D1476–D1485. 4 indexed citations
3.
Hu, Xiao, et al.. (2021). High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer. Translational Cancer Research. 10(3). 1336–1345. 13 indexed citations
4.
Zhou, Yang, et al.. (2021). A Starvation-Based 9-mRNA Signature Correlates With Prognosis in Patients With Hepatocellular Carcinoma. Frontiers in Oncology. 11. 716757–716757. 7 indexed citations
5.
Fang, Qilu, et al.. (2021). MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway. Journal of Gastrointestinal Oncology. 12(4). 1873–1883. 2 indexed citations
6.
7.
Huang, Qin, et al.. (2021). LncRNA MCTP1-AS1 Regulates EMT Process in Endometrial Cancer by Targeting the miR-650/SMAD7 Axis. OncoTargets and Therapy. Volume 14. 751–761. 14 indexed citations
8.
Wang, Dongmei, Jiangyong Gu, Wei Zhu, et al.. (2017). PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis. Annals of Medicine. 49(8). 652–660. 17 indexed citations
9.
Luo, Fang, Jiangyong Gu, Xinzhuang Zhang, et al.. (2015). Multiscale Modeling of Drug-induced Effects of ReDuNing Injection on Human Disease: From Drug Molecules to Clinical Symptoms of Disease. Scientific Reports. 5(1). 10064–10064. 17 indexed citations
10.
Gu, Jiangyong, Xinzhuang Zhang, Yimin Ma, et al.. (2015). Quantitative modeling of dose–response and drug combination based on pathway network. Journal of Cheminformatics. 7(1). 19–19. 18 indexed citations
11.
Dai, Bin, Dan Li, Wenhui Xi, et al.. (2015). Tunable assembly of amyloid-forming peptides into nanosheets as a retrovirus carrier. Proceedings of the National Academy of Sciences. 112(10). 2996–3001. 128 indexed citations
12.
Luo, Fang, Jiangyong Gu, Lirong Chen, & Xiaojie Xu. (2014). Systems pharmacology strategies for anticancer drug discovery based on natural products. Molecular BioSystems. 10(7). 1912–1917. 38 indexed citations
13.
Gu, Jiangyong, Fang Luo, Lirong Chen, Gu Yuan, & Xiaojie Xu. (2014). A systematic study of chemogenomics of carbohydrates. Molecular BioSystems. 10(3). 391–397. 8 indexed citations
14.
Li, Dan, Eric M. Jones, M.R. Sawaya, et al.. (2014). Structure-Based Design of Functional Amyloid Materials. Journal of the American Chemical Society. 136(52). 18044–18051. 96 indexed citations
15.
Zhang, Xinzhuang, Jiangyong Gu, Liang Cao, et al.. (2014). Insights into the inhibition and mechanism of compounds against LPS-induced PGE2production: a pathway network-based approach and molecular dynamics simulations. Integrative Biology. 6(12). 1162–1169. 9 indexed citations
16.
Hao, Ming, Hong Ren, Fang Luo, et al.. (2012). A Computational Study on Thiourea Analogs as Potent MK-2 Inhibitors. International Journal of Molecular Sciences. 13(6). 7057–7079. 5 indexed citations
17.
Hao, Ming, Xiaole Zhang, Hong Ren, et al.. (2011). In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors. International Journal of Molecular Sciences. 12(11). 8161–8180. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I-Lin Lu Breakdown of academic impact, for papers by Benjamin L. Barthel Breakdown of academic impact, for papers by Ho‐Man Chan Breakdown of academic impact, for papers by Fei Peng Breakdown of academic impact, for papers by Debasmita Dutta Breakdown of academic impact, for papers by Thomas J. Paul Breakdown of academic impact, for papers by Huaijiang Xiang Breakdown of academic impact, for papers by Matthew E. Cuellar Breakdown of academic impact, for papers by Jia Ni Breakdown of academic impact, for papers by Paul A. Hubbard
Rankless by CCL
2026